Clinical Trial

AVEIR DR Coverage With Evidence Development (CED) Study

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the dual chamber Aveir Leadless Pacemaker device (aka Aveir™ DR LP system).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-07-05; most recent amendment 2025-04-03.
Status change: Not Yet Recruiting → Recruiting 2023-11-02
Trial Details
NCT Number NCT05932602
Lead Sponsor Abbott Medical Devices
Conditions Cardiac Pacemaker, Arrythmia, Bradycardia
Enrollment 2,812 participants
Start Date 2023-10-31
Primary Completion 2029-05 (estimated)
Study Completion 2030-05 (estimated)
Updated on ClinicalTrials.gov 2025-04-06